T3	SNP 781 790	rs9693444
T4	Entity 794 798	8p12
R1	SNP_location Arg1:T3 Arg2:T4	
T5	Association 803 813	associated
E1	Association:T5 bc:T6 snp_int:T3
T6	Cancer 819 832	breast cancer
T7	Entity 836 849	Chinese women
R2	Population_assignment Arg1:T3 Arg2:T7	
T8	SNP 1050 1059	rs6828523
T9	SNP 1150 1159	rs4849887
T10	SNP 1277 1287	rs12493607
T11	SNP 1371 1381	rs11075995
T12	Association 1261 1273	associations
E2	Association:T12 snp_int:T10 bc:T1
T13	Level 1451 1476	statistically significant
A1	Level E2 High
R3	Population_assignment Arg1:T10 Arg2:T7	
R4	Population_assignment Arg1:T11 Arg2:T7	
T14	Level 974 999	Statistically significant
T15	Association 1035 1046	association
E3	Association:T15 snp_int:T8 bc:T21
A2	Level E3 High
R5	Level_marker Arg1:E3 Arg2:T14	
T16	Association 1135 1146	association
E4	Association:T16 snp_int:T9 bc:T17
A3	Level E4 High
R6	Level_marker Arg1:E4 Arg2:T14	
T17	Cancer 1174 1199	PR-positive breast cancer
A4	Cancer_Type T17 PR+
T18	Entity 1161 1167	2q14.2
R7	SNP_location Arg1:T9 Arg2:T18	
T19	Entity 1061 1067	4q34.1
T20	Entity 1068 1074	ADAM29
R8	SNP_location Arg1:T8 Arg2:T19	
R9	SNP_coupled_gene Arg1:T8 Arg2:T20	
T21	Cancer 1081 1106	ER-positive breast cancer
A5	Cancer_Type T21 ER+
R10	Population_assignment Arg1:T9 Arg2:T7	
R11	Population_assignment Arg1:T8 Arg2:T7	
T1	Cancer 1309 1346	HER-2 overexpression in breast cancer
A6	Cancer_Type T1 HER2+
T2	Cancer 1401 1425	basal-like breast cancer
E5	Association:T12 snp_int:T11 bc:T2
R12	Level_marker Arg1:E5 Arg2:T13	
R13	Level_marker Arg1:E2 Arg2:T13	
A7	Level E5 High
T22	Entity 525 542	estrogen receptor
T24	Entity 556 565	progestin
T26	Entity 579 619	human epidermal growth factor receptor-2
A8	Cancer_Type T2 TNBC_and_or_Basal_like
T23	SNP 468 478	these SNPs
T25	SNP 295 329	40 single nucleotide polymorphisms
T27	Spec 458 467	evaluated
R14	Speculation_marker Arg1:T23 Arg2:T27	
T28	Cancer 496 509	breast cancer
T29	Association 488 492	risk
E6	Association:T29 snp_int:T23 bc:T28 bc2:T33
R15	Speculation_marker Arg1:E6 Arg2:T27	
R16	Equiv Arg1:T23 Arg2:T25	
T30	Entity 544 546	ER
R17	Equiv Arg1:T30 Arg2:T22	
T31	Entity 567 569	PR
R18	Member Arg1:T31 Arg2:T24	
T32	Entity 621 626	HER-2
R19	Member Arg1:T32 Arg2:T26	
T33	Cancer 525 542;556 565;579 619;628 634	estrogen receptor progestin human epidermal growth factor receptor-2 status
A9	Cancer_Type T33 Molec_Status_other
R20	Member Arg1:T23 Arg2:T3	
T34	Entity 254 267	Chinese women
R21	Population_assignment Arg1:T25 Arg2:T34	
R22	Member Arg1:T23 Arg2:T8	
R23	Member Arg1:T23 Arg2:T9	
R24	Member Arg1:T23 Arg2:T10	
R25	Member Arg1:T23 Arg2:T11	
T35	Entity 1289 1295	3p24.1
T36	Entity 1296 1302	TGFBR2
R26	SNP_location Arg1:T10 Arg2:T35	
R27	SNP_coupled_gene Arg1:T10 Arg2:T36	
T37	Entity 1383 1390	16q12.2
T38	Entity 1391 1394	FTO
R28	SNP_location Arg1:T11 Arg2:T37	
R29	SNP_coupled_gene Arg1:T11 Arg2:T38	
